Crizanlizumab

crizanlizumab · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Crizanlizumab, covering 2021-11-09 to 2025-07-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients [Phase 2]